Antitumor and anti-angiogenic activities of Scutellaria barbata extracts in vitro are partially mediated by inhibition of Akt/protein kinase B

Molecular Medicine Reports

Volumn 5, Issue 3, 2012, Pages 788-792

  Zhao, Zhihui ^a   Holle, Lori ^b   Song, When ^b   Wei, Yanzhang ^c   Wagner, Thomas E ^b   Yu, Xianzhong ^a,c  

^a JILIN UNIVERSITY   (China)

^b Orbis Health Solutions   (United States)

^c CLEMSON UNIVERSITY   (United States)

Author keywords

Akt kinase; Inhibitor; Scutellaria barbata extracts

Indexed keywords

ANTINEOPLASTIC AGENT; METHANOL; PLANT EXTRACT; PROTEIN BAD; PROTEIN KINASE B; SCUTELLARIA BARBATA EXTRACT; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PHOSPHORYLATION; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; SCUTELLARIA; SIGNAL TRANSDUCTION;

SCUTELLARIA BARBATA;

EID: 84856254694     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.694     Document Type: Article

References (41)

1. Duronio V, Scheid MP and Ettinger S: Downstream signaling events regulated by phosphatidylinositol 3-kinase activity. Cell Signal 10: 233-239, 1998. (Pubitemid 28205901)
2. Chan TO, Rittenhouse SE and Tsichlis PN: AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68: 965-1014, 1999. (Pubitemid 29449213)
3. Jiang BH, Zheng JZ, Aoki M and Vogt PK: Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA 97: 1749-1753, 2000. (Pubitemid 30118514)
4. Franke TF, Hornik CP, Segev L, Shostak GA and Sugimoto C: PI3K/Akt and apoptosis: size matters. Oncogene 22: 8983-8998, 2003. (Pubitemid 38121699)
5. Jiang BH and Liu LZ: AKT signaling in regulating angiogenesis. Current Cancer Drug Targets 8: 19-26, 2008.
6. Testa JR and Tsichlis PN: Akt signaling in normal and malignant cells. Oncogene 24: 7391-7393, 2005. (Pubitemid 41637978)
7. Cheng GZ, Park S, Shu S, et al: Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets 8: 2-6, 2008. (Pubitemid 351237904)
8. Vivanco I and Sawyers CL: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002. (Pubitemid 37328931)
9. +/- mice. Science 285: 2122-2125, 1995.
10. Hill MM and Hemmings B: Inhibition of protein kinase B/Akt. Implications for cancer therapy. Pharmacol Ther 93: 243-251, 2002. (Pubitemid 34615565)
11. Nicholson KM and Anderson NG: The protein kinase B/Akt signaling pathway in human malignancy. Cell Signal 14: 381-395, 2002. (Pubitemid 34214843)
12. Testa JR and Bellacosa A: AKT plays a central role in tumorigenesis. Proc Natl Acad Sci USA 98: 10983-10985, 2001. (Pubitemid 32928669)
13. Osaki M, Oshimura M and Ito H: PI3K-Akt pathway: Its functions and alterations in human cancer. Apoptosis 9: 667-676, 2004. (Pubitemid 40941196)
14. Hennessy BT, Smith DL, Ram PT, Lu Y and Mills GB: Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004, 2005.
15. Altomare DA and Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene 24: 7455-7464, 2005. (Pubitemid 41637985)
16. Tokunaga E, Oki E, Egashira A, Sadanaga N, Morita M, Kakeji Y and Maehara Y: Deregulation of the Akt pathway in human cancer. Curr Cancer Drug Targets 8: 27-36, 2008. (Pubitemid 351237907)
17. Kumar CC and Madison V: AKT crystal structure and AKT-specific inhibitors. Oncogene 24: 7493-7501, 2005. (Pubitemid 41637989)
18. Cheng JQ, Lindsley CW, Cheng GZ, Yang H and Nicosia SV: The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 24: 7482-7492, 2005. (Pubitemid 41637988)
19. Yoeli-Lerner M and Toker A: Akt/PKB signaling in cancer: a function in cell motility and invasion. Cell Cycle 5: 603-605, 2006.
20. Chen YL, Law PY and Loh HH: Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy. Curr Med Chem Anticancer Agents 5: 575-589, 2005. (Pubitemid 41601056)
21. Lu Y, Wang H and Mills GB: Targeting PI3K-AKT pathway for cancer therapy. Rev Clin Exp Hematol 7: 205-228, 2003. (Pubitemid 37466220)
22. Li, Q: Recent progress in the discovery of Akt inhibitor as anticancer agents. Expert opin ther patents 17: 1077-1130, 2007.
23. Qian B: Clinical Effect of Anticancer Chinese Medicine. Shanghai Translation Publishing House, pp 6-7, 1987.
24. Kim KW, Jin UH, Kim DI, et al: Antiproliferative effect of Scutellaria barbata D. Don. on cultured human uterine leiomyoma cells by down-regulation of the expression of Bcl-2 protein. Phytother Res 22: 583-590, 2008.
25. Suh SJ, Yoon JW, Lee TK, et al: Chemoprevention of Scutellaria bardata on human cancer cells and tumorigenesis in skin cancer. Phytother Res 21: 135-141, 2007.
26. Goh D, Lee YH and Ong ES: Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem 53: 8197-8204, 2005. (Pubitemid 41564626)
27. Lin JM, Liu Y and Luo RC: Inhibition activity of Scutellariae barbata extracts against human hepatocellular carcinoma cells. Nanfang Yikedadue Xuebao 26: 591-593, 2006.
28. Yin X, Zhou J, Jie C, Xing D and Zhang Y: Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci 75: 2233-2244, 2004. (Pubitemid 39120026)
29. Cha YY, Lee EO, Lee HJ, et al: Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway. Clin Chim Acta 348: 41-48, 2004.
30. Yu J, Liu H, Lei J, Tan W, Hu X and Zou G: Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res 21: 817-822, 2007. (Pubitemid 47401849)
31. Lee TK, L.D., Kim DI, Lee YC, Chang YC and Kim CH: Inhibitory effects of Scutellaria barbata D. Don on human uterine leiomyomal smooth muscle cell proliferation through cell cycle analysis. Int Immunopharmacol 4: 447-454, 2004.
32. Bui-Xuan NH, Tang PM, Wong CK and Fung KP: Photo-activated pheophorbide-a, an active component of Scutellaria barbata, enhances apoptosis via the suppression of ERK-mediated autophagy in the estrogen receptor-negative human breast adenocarcinoma cells MDA-MB-231. J Ethnopharmacol 131: 95-103, 2010.
33. Dai ZJ, Wang XJ, Li ZF, et al: Scutellaria barbate extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3. World J Gastroenterol 14: 7321-7328, 2008.
34. Wong BY, Nguyen DL, Lin T, et al: Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev 18: 331-341, 2009.
35. Fong S, Shoemaker M, Cadaoas J, et al: Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells. Cancer Biol Ther 7: 577-586, 2008. (Pubitemid 351847034)
36. Luo Y, Shoemaker AR, Liu X, et al: Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. Mol Cancer Ther 4: 977-986, 2005. (Pubitemid 40909080)
37. Hoffman K, Holmes FA, Fraschini G, et al: Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer. Cancer Chemother Pharmacol 37: 254-258, 1996.
38. Zhu GD, Gandhi VB, Gong J, et al: Syntheses of potent, selective, and orally bioavailable indazole-pyridine series of protein kinase B/Akt inhibitors with reduced hypotension. J Med Chem 50: 2990-3003, 2007. (Pubitemid 47001242)
39. Xia C, Meng Q, Cao Z, Shi X and Jiang BH: Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression. J Cell Physiol 209: 56-66, 2006. (Pubitemid 44318667)
40. Su JD, Mayo LD, Donner DB and Durden DL: PTEN and phosphatidylinositol 3′-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment. Cancer Res 68: 635-643, 2003.
41. Wong WR, Chen YY, Yang SM, Chen YL and Horng JT: Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci 78: 82-90, 2005.